| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/09/2006 | CN1813716A Use of indole-2,3-dione for preparing medicine for cardio-cerehral vascular disease |
| 08/09/2006 | CN1813715A Ginkgolide B dropping pill and its preparing method |
| 08/09/2006 | CN1813714A Ginkgolide B soft capsule and its preparing method |
| 08/09/2006 | CN1813712A Method for preparing soybean isoflavone tablet |
| 08/09/2006 | CN1813711A Use of isoflavone compound |
| 08/09/2006 | CN1813710A Method for preparing flavone aglycone micro capsule |
| 08/09/2006 | CN1813709A Safflower yellow dropping pill, and its preparing method and use |
| 08/09/2006 | CN1813708A Amiodarone hydro chloride dispensible tablet, and its preparing method |
| 08/09/2006 | CN1813707A Medicinal composition containing isosorbide mononitrate for treating hypertension |
| 08/09/2006 | CN1813706A Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage |
| 08/09/2006 | CN1813705A Chlorogenic acid injection, its preparing method and use |
| 08/09/2006 | CN1813704A Magnesium chlorogenate medicinal composition, its preparing method and use |
| 08/09/2006 | CN1813701A Medicine, health product and food additive containing rare-earth element non-polysaccharide compound |
| 08/09/2006 | CN1813693A Dopexamine hydrochloride injection and its preparing method |
| 08/09/2006 | CN1813677A Quercetin long-acting liposome powder for injection and its preparing method |
| 08/09/2006 | CN1268744C Novel neurotrophic factors |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268364C Medicine for treating cerebral hemorrhage and its preparing method |
| 08/09/2006 | CN1268361C Chinese traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/09/2006 | CN1268339C Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268331C Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268326C Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 08/09/2006 | CN1268322C Pharmaceutical compositions comprising amlodipine maleate |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087716 Regulator of G protein signalling |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087620 Cardiovascular disorders; contorlling artrial fibrillation |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087602 Cinnoline derivatives and use as medicine |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087259 Can be used for the production of beverages having, despite a high polyphenol content, a low degree of bitterness acceptable to the consumer |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/08/2006 | CA2207258C Xanthine compounds having terminally aminated alkynol side chains |
| 08/03/2006 | WO2006081517A2 Embolization using poly-4-hydroxybutyrate particles |
| 08/03/2006 | WO2006081431A2 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | WO2006080884A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080533A1 3-amino-1,2,4-triazole derivative |
| 08/03/2006 | WO2006080524A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080407A1 Ppar-activating compound |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080199A1 Patch |
| 08/03/2006 | WO2006079988A1 7- {4- [2- (2 , 6-dichl0r0-4-methylphen0xy) ethoxy] phenyl}-3 , 9-diazabicyclo [3 .3 . 31] non - 6-ene- s- carboxylic acid cyclopropyl- (2 , 3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension |
| 08/03/2006 | WO2006079829A1 Phosphoglycerides for use in improving heart rate recovery and increasing exercise capacity |
| 08/03/2006 | WO2006079625A2 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 08/03/2006 | WO2006079610A1 Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
| 08/03/2006 | WO2006079496A1 New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance |
| 08/03/2006 | WO2006079474A1 Prevention and treatment of thromboembolic disorders |
| 08/03/2006 | WO2006079217A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | WO2006053037A3 A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human |
| 08/03/2006 | WO2006050509A3 Amorphous and polymorphic forms of telmisartan sodium |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | WO2006032115A3 Composition against cardiovascular diseases |
| 08/03/2006 | WO2006000339A3 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 08/03/2006 | US20060173059 Agent for preventing or treating portal hypertension |
| 08/03/2006 | US20060173057 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173024 Compositions and methods for treating heart failure |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172921 Method for identifying active anti-apoptosis compounds |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |